Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. 1990

W R Weiss, and S Mellouk, and R A Houghten, and M Sedegah, and S Kumar, and M F Good, and J A Berzofsky, and L H Miller, and S L Hoffman
Infectious Disease Department, Naval Medical Research Institute, Bethesda, Maryland 20814.

Irradiated malaria sporozoites can induce CD8+ T cells that are required for protection against infection. However, the parasite antigens targeted by this immune response are unknown. We have discovered a 16-amino acid epitope from the Plasmodium yoelii circumsporozoite (CS) protein that is recognized by cytotoxic T cells from immune mice. Lymphocytes stimulated with this peptide can kill P. yoelii liver stage parasites in vitro in an MHC-restricted, antigen-specific manner. Thus, epitopes from the CS protein are presented on the surface of infected hepatocytes and can be targets for T cells, even though intact CS protein has not been detected on the surface of the infected hepatocyte. A vaccine that induced CTL to parasite antigens might protect humans against malaria by eliminating liver stage parasites.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010967 Plasmodium yoelii A species of PLASMODIUM causing malaria in rodents. Plasmodium yoelius,yoelius, Plasmodium
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic

Related Publications

W R Weiss, and S Mellouk, and R A Houghten, and M Sedegah, and S Kumar, and M F Good, and J A Berzofsky, and L H Miller, and S L Hoffman
September 1989, Nature,
W R Weiss, and S Mellouk, and R A Houghten, and M Sedegah, and S Kumar, and M F Good, and J A Berzofsky, and L H Miller, and S L Hoffman
June 2000, Infection and immunity,
W R Weiss, and S Mellouk, and R A Houghten, and M Sedegah, and S Kumar, and M F Good, and J A Berzofsky, and L H Miller, and S L Hoffman
October 1990, The Journal of experimental medicine,
W R Weiss, and S Mellouk, and R A Houghten, and M Sedegah, and S Kumar, and M F Good, and J A Berzofsky, and L H Miller, and S L Hoffman
August 1990, Immunology letters,
W R Weiss, and S Mellouk, and R A Houghten, and M Sedegah, and S Kumar, and M F Good, and J A Berzofsky, and L H Miller, and S L Hoffman
July 1988, Nature,
W R Weiss, and S Mellouk, and R A Houghten, and M Sedegah, and S Kumar, and M F Good, and J A Berzofsky, and L H Miller, and S L Hoffman
February 1994, The Journal of experimental medicine,
W R Weiss, and S Mellouk, and R A Houghten, and M Sedegah, and S Kumar, and M F Good, and J A Berzofsky, and L H Miller, and S L Hoffman
June 2007, Journal of immunology (Baltimore, Md. : 1950),
W R Weiss, and S Mellouk, and R A Houghten, and M Sedegah, and S Kumar, and M F Good, and J A Berzofsky, and L H Miller, and S L Hoffman
September 2018, Nature medicine,
W R Weiss, and S Mellouk, and R A Houghten, and M Sedegah, and S Kumar, and M F Good, and J A Berzofsky, and L H Miller, and S L Hoffman
October 1991, International immunology,
W R Weiss, and S Mellouk, and R A Houghten, and M Sedegah, and S Kumar, and M F Good, and J A Berzofsky, and L H Miller, and S L Hoffman
April 1988, European journal of immunology,
Copied contents to your clipboard!